Latest news

3 Apr 2020 Immuno-oncology
Could tocilizumab reduce COVID-19 symptoms for blood cancer patients?
3 Apr 2020 Brain and neurologic
3D-printed brains could aid physicians understanding of glioblastoma
2 Apr 2020 Prostate
Ipilimumab could be effective in metastatic prostate cancers despite low tumor mutational burden
2 Apr 2020 Quality of life and outcomes
COVID-19: how can we prevent cancer patient infection?

Video

View all videos

17 Feb 2020 Videos
Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices

Video

View all videos

Features

Interviews

Spotlights

Journal articles

Stay up to date

Upcoming event

Molecular Analysis for Personalised Therapy Congress 2020

October 8, 2020 – October 10, 2020

Amsterdam, Netherlands

View all

Upcoming event

ESMO World Congress of Gastrointestinal Cancer 2020

July 1, 2020 – July 4, 2020

Barcelona, Spain

View all

Tweets

Oncology Central @OncologyCentral·

Could a novel blood test change the way we screen cancer? Find out more: https://t.co/m0ijJZxw3G

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Our mission statement

At Oncology Central we are dedicated to advancing oncology by publishing trusted, engaging and insightful resources for the global oncology community.

Learn more

Could tocilizumab reduce COVID-19 symptoms for blood cancer patients?

3D-printed brains could aid physicians understanding of glioblastoma

Ipilimumab could be effective in metastatic prostate cancers despite low tumor mutational burden

COVID-19: how can we prevent cancer patient infection?

The best of 2019: an A–Z of cancer research and care

The future of liquid biopsies: an interview with Bob Li

Pharma, President, Patients: the cancer cost conundrum

How could a “pre-cancer genome atlas” transform cancer prevention?

Panel discussion: the future of oncology

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices

Video

Login

Latest news

Could tocilizumab reduce COVID-19 symptoms for blood cancer patients?

3D-printed brains could aid physicians understanding of glioblastoma

Ipilimumab could be effective in metastatic prostate cancers despite low tumor mutational burden

COVID-19: how can we prevent cancer patient infection?

Featured articles

The best of 2019: an A–Z of cancer research and care

The future of liquid biopsies: an interview with Bob Li

Pharma, President, Patients: the cancer cost conundrum

How could a “pre-cancer genome atlas” transform cancer prevention?

Panel discussion: the future of oncology

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices

Video

How could comprehensive genomic profiling bring cancer from uncertainty to focus?

Lung Cancer Ambition Alliance with Giorgio Scagliotti

How could comprehensive genomic profiling bring cancer from uncertainty to focus?

In Focus: lung cancer

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Features

Interviews

Spotlights

Journal articles

Stay up to date

Oncology Central Newsletter